Literature DB >> 2035530

Genetic and environmental explanations for the distribution of sodium-lithium countertransport in pedigrees from Rochester, MN.

T R Rebbeck1, S T Turner, V V Michels, P P Moll.   

Abstract

An elevated level of erythrocyte sodium-lithium (Na-Li) countertransport has been suggested as a predictor of predisposition to essential hypertension. In order to evaluate whether a single genetic or environmental factor with large effects explains the mixture of distributions in Na-Li countertransport in the general population, complex segregation analyses were conducted by using 1,273 individuals more than age 20 years from 276 pedigrees selected without respect to disease risk factors or health status. Either a single genetic locus or a single environmental factor with large gender-specific effects explained the mixture of distributions for Na-Li countertransport in this sample equally well. In the subsample of pedigrees supporting a single-locus etiology, the single genetic locus explained 29.0% of the variability in adjusted Na-Li countertransport in males and 16.6% of that in females. In a subsample of pedigrees supporting an environmental factor etiology, the environmental factor explained 35.2% of the adjusted Na-Li countertransport in males and 20.5% of that in females. These results suggest that there are at least two different explanations for the mixture of distributions in Na-Li countertransport in the general population. Attempts to relate genetic variation in Na-Li countertransport to risk of essential hypertension must consider that the factor with large phenotypic effects on this trait is gender specific and may not be a single major locus in all pedigrees.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035530      PMCID: PMC1683120     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

2.  Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000.

Authors:  C Izzo; F Grillo; E Murador
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

3.  A unified model for complex segregation analysis.

Authors:  J M Lalouel; D C Rao; N E Morton; R C Elston
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

4.  The role of the genetics of sodium lithium countertransport in the determination of blood pressure variability in the population at large.

Authors:  E Boerwinkle; S T Turner; C F Sing
Journal:  Prog Clin Biol Res       Date:  1984

5.  Improved method for determination of triglycerides in plasma lipoproteins by an enzymic kit method.

Authors:  S I Barr; B A Kottke; S J Mao
Journal:  Clin Chem       Date:  1981-06       Impact factor: 8.327

6.  A mixed-model likelihood approximation on large pedigrees.

Authors:  S J Hasstedt
Journal:  Comput Biomed Res       Date:  1982-06

7.  Genetic analysis of sodium-lithium countertransport in 10 hypertension-prone kindreds.

Authors:  M M Dadone; S J Hasstedt; S C Hunt; J B Smith; K O Ash; R R Williams
Journal:  Am J Med Genet       Date:  1984-03

8.  Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age.

Authors:  S T Turner; W H Weidman; V V Michels; T J Reed; C L Ormson; T Fuller; C F Sing
Journal:  Hypertension       Date:  1989-04       Impact factor: 10.190

9.  Apolipoproteins and coronary artery disease.

Authors:  B A Kottke; A R Zinsmeister; D R Holmes; R W Kneller; B J Hallaway; S J Mao
Journal:  Mayo Clin Proc       Date:  1986-05       Impact factor: 7.616

10.  Sodium-lithium countertransport and blood pressure in healthy blood donors.

Authors:  S T Turner; M Johnson; E Boerwinkle; E Richelson; H F Taswell; C F Sing
Journal:  Hypertension       Date:  1985 Nov-Dec       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.